Could or should we use MCDA in the French HTA process?

PharmacoEconomics

3 December 2019 - Over the last decade, an increasing literature has been highlighting the benefits of introducing multi-criteria decision analysis in healthcare decision processes, including the emerging ISPOR Good Practices Task Force.

Based on decision theory dating back to the 1960s, multi-criteria decision analysis constitutes a tool to address complex decisions involving multiple criteria, especially where other methods fail to consider more than the outcome of interest. 

A set of criteria is first established; weights and scores are combined with performance data for each alternative. This allows for the generation of an estimate of the relative value of alternative courses of action.

Read PharmacoEconomics Editorial

Michael Wonder

Posted by:

Michael Wonder